| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |